Skip to main content
SpringerLink
Log in

Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jarius S, Jacobi C, de Seze J et al (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17:1067–1073. https://doi.org/10.1177/1352458511403958

    Article  CAS  PubMed  Google Scholar 

  2. Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189. https://doi.org/10.1212/WNL.0000000000001729

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chen C, Xiaobo S, Yuge W et al (2016) Multiple autoantibodies and neuromyelitis optica spectrum disorders. NeuroImmunoModulation 23:151–156. https://doi.org/10.1159/000448286

    Article  CAS  PubMed  Google Scholar 

  4. Pittock SJ, Lennon VA, de Seze J et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78–83. https://doi.org/10.1001/archneurol.2007.17

    Article  PubMed  Google Scholar 

  5. Pereira WLCJ, Reiche EMV, Kallaur AP et al (2017) Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica. Acta Neuropsychiatr 29:170–178. https://doi.org/10.1017/neu.2016.49

    Article  PubMed  Google Scholar 

  6. Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:134. https://doi.org/10.1186/s12974-018-1144-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Theodora Gkaniatsou and Athina Papadopoulou have contributed equally to this work.

Authors and Affiliations

  1. Experimental and Clinical Research Center, Max Delbrück Centre for Molecular Medicine and Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

    Theodora Gkaniatsou, Athina Papadopoulou, Friedemann Paul, Alexander Ulrich Brandt & Frederike Cosima Oertel

  2. NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

    Theodora Gkaniatsou, Athina Papadopoulou, Friedemann Paul, Alexander Ulrich Brandt & Frederike Cosima Oertel

  3. Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedicine University Hospital Basel, University of Basel, Basel, Switzerland

    Athina Papadopoulou

  4. Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

    Friedemann Paul

  5. Department of Neurology, University of California, Irvine, CA, USA

    Alexander Ulrich Brandt

Authors
  1. Theodora Gkaniatsou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Athina Papadopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Friedemann Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexander Ulrich Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frederike Cosima Oertel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Ulrich Brandt.

Ethics declarations

Conflict of interest

The authors report no potential conflict of interest regarding this letter. TG has nothing to disclosure. AP has received speaker-fee from Sanofi-Genzyme and travel support from Bayer AG, Teva, Hoffmann-La Roche and ECTRIMS. Her research was supported by the University of Basel, the Swiss Multiple Sclerosis Society and the “Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie
der medizinischen Bildauswertung”. The current research work was supported by the Swiss National Science Foundation (Project number: P300PB_174480). FP serves on the scientific advisory board for Novartis; received speaker honoraria and travel funding from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme, Merck Serono, Alexion, Chugai, MedImmune, and Shire; is an academic editor for PLoS ONE; is an associate editor for Neurology® Neuroimmunology & Neuroinflammation; consulted for SanofiGenzyme, Biogen Idec, MedImmune, Shire, and Alexion; and received research support from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme, Alexion, Merck Serono, German Research Council, Werth Stiftung of the City of Cologne, German Ministry of Education and Research, Arthur Arnstein Stiftung Berlin, EU FP7 Framework Program, Arthur Arnstein Founda-tion Berlin, Guthy Jackson Charitable Foundation, and National Multiple Sclerosis of the USA. AUB is cofounder and shareholder of technology startups Motognosis and Nocturne. He is named as inventor on several patent applications describing MS serum biomarkers, perceptive visual computing and retinal image analysis. FCO was employed by Nocturne, unrelated to this project.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All patients gave written informed consent. This article does not contain any studies with animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gkaniatsou, T., Papadopoulou, A., Paul, F. et al. Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg 120, 223–225 (2020). https://doi.org/10.1007/s13760-019-01176-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01176-6

Search

Navigation